Vanguard Personalized Indexing Management, LLC Protagonist Therapeutics, Inc Transaction History
Vanguard Personalized Indexing Management, LLC
- $9.45 Billion
- Q3 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 3,298 shares of PTGX stock, worth $252,494. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,298Holding current value
$252,494% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PTGX
# of Institutions
297Shares Held
67.3MCall Options Held
290KPut Options Held
318K-
Farallon Capital Management LLC San Francisco, CA6.17MShares$473 Million1.53% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$441 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.76MShares$441 Million4.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.36MShares$334 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.25MShares$249 Million6.36% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $3.76B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...